PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930087
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930087
The global empty capsules market was valued at USD 3.67 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to USD 6.58 billion by 2034, registering a CAGR of 6.74% during the forecast period. North America dominated the market with a 33.66% share in 2025, supported by high diagnosis and treatment rates, strong preference for capsule-based dosage forms, and rising consumption of dietary supplements.
Empty capsules are shells used to enclose active pharmaceutical ingredients and inert substances. These capsules are commonly manufactured using gelatin, hydroxypropyl methylcellulose (HPMC), starch, or pullulan. The growing adoption of capsule formulations by pharmaceutical manufacturers, increasing nutraceutical demand among the aging population, and expanding use of capsules in cosmeceutical and food industries are key factors driving market growth.
Market Snapshot & Key Highlights
Impact of COVID-19
The COVID-19 pandemic positively influenced the empty capsules market due to increased consumption of dietary supplements such as vitamins and minerals to boost immunity. Major market players witnessed revenue growth during this period. For instance, Natural Capsules Limited reported revenue growth from USD 8.3 million in FY 2019 to USD 10.8 million in FY 2020. Post-pandemic, the market stabilized, with manufacturers focusing on expanding HPMC capsule production for domestic and international markets.
Market Trends
Rising Demand for Liquid-Filled Hard Capsules
A notable trend in the market is the increasing preference for liquid-filled hard capsules (LFHCs) over softgel capsules. Softgel capsules are hygroscopic and prone to degradation during moisture equilibrium. To overcome these limitations, manufacturers are shifting toward hard gelatin and HPMC capsules, which offer better stability, longer shelf life, and resistance to higher temperatures.
For example, in February 2022, CapsCanada received approval for a liquid-filled aspirin capsule, while in March 2021, the company launched a liquid-filled hard capsule manufacturing service in North America. These developments are contributing significantly to market growth.
Market Growth Drivers
Expansion Strategies and New Product Launches
The growing aging population has led to increased prevalence of joint, bone, gastrointestinal, and musculoskeletal disorders, boosting demand for pharmaceutical and nutraceutical products. This trend has encouraged manufacturers to expand production capacities, launch new products, and acquire competitors.
For instance, in December 2022, Vantage Nutrition (ACG Group) acquired AquaCap, strengthening its manufacturing capabilities. Similarly, Vivion (Operio Group) launched new gelatin, HPMC, and pullulan capsules in February 2023, expanding customer offerings.
Rising Demand for Nutraceutical Capsules
Increasing health awareness, preventive healthcare adoption, and post-pandemic immunity concerns have fueled demand for nutraceutical products in capsule form. A large portion of the global population now prefers dietary supplements for long-term health management, boosting demand for vegetarian and HPMC capsules.
According to industry articles, around 77% of American adults consume dietary supplements, and nearly 50% of nutraceutical products in the U.S. and Europe use vegetarian capsules, significantly supporting market growth.
Market Restraint
Rising Raw Material Prices
The market faces challenges due to inflating prices of raw materials, particularly gelatin and HPMC. Increased demand from pharmaceutical, food, and nutraceutical industries, coupled with geopolitical disruptions and high crude oil prices, has raised production costs. For example, HPMC prices in India reached USD 6,015.6 per metric ton in 2022, impacting manufacturers' profit margins.
By Type
The gelatin segment dominated the market in 2024 due to its widespread pharmaceutical use and manufacturing efficiency. However, HPMC capsules are expected to grow at the highest CAGR owing to their vegetarian nature, low moisture content, stability, and compliance with dietary preferences.
By Functionality
The immediate-release segment led the market with 65.98% share in 2026, driven by high demand for antacids and antibiotics. Sustained and delayed-release capsules are expected to grow at a slower pace due to higher costs and formulation complexities.
By End User
Pharmaceutical companies dominated the market with a 59.13% share in 2026, supported by rising disease prevalence and government incentives. Nutraceutical manufacturers are expected to grow at the fastest rate due to increasing consumer preference for dietary supplements.
Competitive Landscape
The market is consolidated, led by companies such as Lonza, ACG, QUALICAPS, CapsCanada, Natural Capsules Limited, and Nectar Lifesciences. Players are focusing on product innovation, geographic expansion, and TiO2-free capsule development to strengthen their market position.
Conclusion
The global empty capsules market, valued at USD 3.67 billion in 2025, grew to USD 3.91 billion in 2026 and is projected to reach USD 6.58 billion by 2034. Market growth is driven by rising pharmaceutical and nutraceutical demand, technological advancements in capsule delivery, and expanding use of vegetarian capsules. Although raw material price volatility remains a challenge, ongoing innovation, strategic expansions, and increasing healthcare awareness are expected to sustain market growth throughout the forecast period.
By Type, Functionality, End User, and Region
Segmentation By Type
By Functionality
By End User
By Region